Susan E. Libretto

572 total citations
25 papers, 381 citations indexed

About

Susan E. Libretto is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Susan E. Libretto has authored 25 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Physiology. Recurrent topics in Susan E. Libretto's work include Schizophrenia research and treatment (5 papers), Pain Mechanisms and Treatments (3 papers) and Mental Health and Psychiatry (3 papers). Susan E. Libretto is often cited by papers focused on Schizophrenia research and treatment (5 papers), Pain Mechanisms and Treatments (3 papers) and Mental Health and Psychiatry (3 papers). Susan E. Libretto collaborates with scholars based in United Kingdom, Switzerland and Germany. Susan E. Libretto's co-authors include M. S. Chong, David Cowan, Peter Griffiths, L. Allan, Jehan Aram, Cris S. Constantinescu, Roman Korolkiewicz, Frank Wagner, Maren Dirnberger‐Hertweck and Waldemar Fryze and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Psychiatry and Archives of Toxicology.

In The Last Decade

Susan E. Libretto

25 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Libretto United Kingdom 10 83 78 64 47 46 25 381
Shu‐Chuan Wu Taiwan 13 36 0.4× 49 0.6× 44 0.7× 80 1.7× 17 0.4× 33 420
Ana Cristina Martı́nez Spain 16 139 1.7× 194 2.5× 29 0.5× 110 2.3× 44 1.0× 42 656
Henrik Horwitz Denmark 13 47 0.6× 14 0.2× 23 0.4× 127 2.7× 41 0.9× 57 562
Eugene Gusev Russia 14 82 1.0× 51 0.7× 17 0.3× 64 1.4× 46 1.0× 30 561
Jean‐Louis Montastruc France 12 28 0.3× 50 0.6× 17 0.3× 63 1.3× 15 0.3× 16 413
J P Buyniski United States 11 22 0.3× 69 0.9× 30 0.5× 130 2.8× 18 0.4× 20 398
Asieh Naderi Iran 11 28 0.3× 77 1.0× 15 0.2× 77 1.6× 14 0.3× 25 393
Maria Rosaria Tola Italy 16 83 1.0× 51 0.7× 49 0.8× 42 0.9× 71 1.5× 23 633
Annelize Koch United Kingdom 14 19 0.2× 91 1.2× 42 0.7× 127 2.7× 37 0.8× 24 550
Dry J France 11 99 1.2× 162 2.1× 26 0.4× 34 0.7× 29 0.6× 101 514

Countries citing papers authored by Susan E. Libretto

Since Specialization
Citations

This map shows the geographic impact of Susan E. Libretto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Libretto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Libretto more than expected).

Fields of papers citing papers by Susan E. Libretto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Libretto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Libretto. The network helps show where Susan E. Libretto may publish in the future.

Co-authorship network of co-authors of Susan E. Libretto

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Libretto. A scholar is included among the top collaborators of Susan E. Libretto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Libretto. Susan E. Libretto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Constantinescu, Cris S., Waldemar Fryze, Wojciech Kozubski, et al.. (2015). Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 2(4). e117–e117. 83 indexed citations
2.
Prasad, Suyash, et al.. (2009). Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK. International Journal of Clinical Practice. 63(7). 1031–1040. 13 indexed citations
3.
Dratcu, Luiz, et al.. (2005). Risperidone long-acting injection, a promising treatment for patients with bipolar disorder. Journal of Mental Health. 14(5). 523–529. 1 indexed citations
4.
Jayawant, Sandeep & Susan E. Libretto. (2004). Topiramate in the treatment of myoclonic-astatic epilepsy in children: a retrospective hospital audit.. SHILAP Revista de lepidopterología. 49(3). 202–5; discussion 205. 10 indexed citations
5.
Reveley, Michael A. & Susan E. Libretto. (2004). Treatment Outcome in Patients With Chronic Schizophrenia During Long-term Administration With Risperidone. Journal of Clinical Psychopharmacology. 24(3). 260–267. 3 indexed citations
6.
Libretto, Susan E., et al.. (2004). Hypersensitivity to Topiramate Sprinkle Capsules Does not Preclude the Use of Topiramate Tablets. Pediatric Drugs. 6(2). 133–135. 1 indexed citations
7.
Dale, Mark, et al.. (2003). Clinical experience of galantamine in dementia: a series of case reports. Current Medical Research and Opinion. 19(6). 508–518. 4 indexed citations
8.
Chong, M. S. & Susan E. Libretto. (2003). The Rationale and Use of Topiramate for Treating Neuropathic Pain. Clinical Journal of Pain. 19(1). 59–68. 76 indexed citations
9.
Martin, S, et al.. (2003). Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone. Current Medical Research and Opinion. 19(4). 298–305. 15 indexed citations
10.
Taylor, David, et al.. (2003). Risperidone Compared With Olanzapine in a Naturalistic Clinical Study. The Journal of Clinical Psychiatry. 64(5). 589–597. 16 indexed citations
11.
Johnson, Martin, et al.. (2002). Patients Have Treatment Preferences: A Multicentre, Double-blind, Crossover Study Comparing Rabeprazole and Omeprazole. Current Medical Research and Opinion. 18(5). 303–310. 10 indexed citations
12.
Libretto, Susan E.. (2002). Use of Transdermal Fentanyl in Patients with Continuous Non-Malignant Pain. Clinical Drug Investigation. 22(7). 473–483. 2 indexed citations
13.
Fear, Christopher & Susan E. Libretto. (2002). Risperidone for the treatment of delusional disorder. International Journal of Psychiatry in Clinical Practice. 6(2). 113–116. 4 indexed citations
14.
Libretto, Susan E., et al.. (2002). Risperidone in Children and Adolescents with Autistic Disorder and Aggressive Behaviour. The British Journal of Development Disabilities. 48(95). 113–122. 9 indexed citations
15.
Libretto, Susan E., Peter Barrett‐Lee, Kristin Branson, et al.. (2001). Improvement in quality of life for cancer patients treated with epoetin alfa. European Journal of Cancer Care. 10(3). 183–191. 8 indexed citations
16.
Cowan, David, L. Allan, Susan E. Libretto, & Peter Griffiths. (2001). Opioid Drugs: A Comparative Survey of Therapeutic and "Street" Use. Pain Medicine. 2(3). 193–203. 36 indexed citations
17.
McCloskey, Eugène & Susan E. Libretto. (1998). Use of Bisphosphonates in the Treatment of Multiple Myeloma. Hematology. 3(4). 291–298. 1 indexed citations
18.
Libretto, Susan E.. (1995). Review of the toxicology of beclomethasone dipropionate. Archives of Toxicology. 69(8). 509–525. 6 indexed citations
19.
Libretto, Susan E.. (1994). A review of the toxicology of salbutamol (albuterol). Archives of Toxicology. 68(4). 213–216. 56 indexed citations
20.
Owen, Kelly P., et al.. (1994). Toxicity of a Novel HMG-CoA Reductase Inhibitor in the Common Marmoset (Callithrix jacchus). Human & Experimental Toxicology. 13(5). 357–368. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu‐Chuan Wu Breakdown of academic impact, for papers by Ana Cristina Martı́nez Breakdown of academic impact, for papers by Henrik Horwitz Breakdown of academic impact, for papers by Eugene Gusev Breakdown of academic impact, for papers by Jean‐Louis Montastruc Breakdown of academic impact, for papers by J P Buyniski Breakdown of academic impact, for papers by Asieh Naderi Breakdown of academic impact, for papers by Maria Rosaria Tola Breakdown of academic impact, for papers by Annelize Koch Breakdown of academic impact, for papers by Dry J
Rankless by CCL
2026